Improved Glycemic Control With Intraperitoneal Versus Subcutaneous Insulin in Type 1 Diabetes: A randomized controlled trial

OBJECTIVE: Continuous intraperitoneal insulin infusion (CIPII) with an implantable pump has been available for the past 25 years. CIPII, with its specific pharmacodynamic properties, may be a viable treatment alternative to improve glycemic control in patients with type 1 diabetes for whom other the...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Logtenberg, Susan J., Kleefstra, Nanne, Houweling, Sebastiaan T., Groenier, Klaas H., Gans, Reinold O., van Ballegooie, Evert, Bilo, Henk J.
Format: Artigo
Jezik:Inglês
Izdano: American Diabetes Association 2009
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2713651/
https://ncbi.nlm.nih.gov/pubmed/19429874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc08-2340
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items